Company Overview
Snapshot
Founded in March 2024 by Rom Kshuk, Ayal Hendel, and Yaniv Shmueli, Cassidy Bio operates with 11–50 employees. The company has raised $8M across one funding round from 5 investors, including Ahren Innovation Capital. In August 2024, Cassidy Bio secured its seed funding round.
Business overview
Cassidy Bio is an AI-first biotechnology company developing a programmable platform for gene editing. The company's core technology replaces traditional trial-and-error design processes with large-scale prediction, simulation, and in silico validation, powered by genomic foundation models trained on proprietary biological data. This platform connects across multiple components, including guides, editing systems, delivery systems, and variant backgrounds, to rank designs by safety and efficacy. Cassidy Bio aims to enable a new generation of reliable gene editing therapies at scale, serving the pharmaceuticals and biotechnology sectors within the broader Health Tech & Life Sciences industry.
Strategic signal
Cassidy Bio's seed funding in August 2024, which included participation from investors like Ahren Innovation Capital, signals strong early investor confidence in its AI-first approach to gene editing. This capital infusion validates the company's vision to revolutionize therapy development by improving safety and specificity, positioning it as a key innovator in the rapidly evolving field of genomic medicine.
Log in to access full profile ›Company Intelligence Q&A
- When was Cassidy Bio founded?
- Cassidy Bio was founded in March 2024.
- Who are the founders of Cassidy Bio?
- The founders of Cassidy Bio are Rom Kshuk, Ayal Hendel, and Yaniv Shmueli.
- What is Cassidy Bio's primary focus?
- Cassidy Bio is an AI-first biotechnology company focused on building a programmable platform for gene editing to develop reliable gene editing therapies at scale.
- What was a key development for Cassidy Bio in August 2024?
- In August 2024, Cassidy Bio secured its Seed funding round, raising $8M from investors including.
- What is the strategic importance of Cassidy Bio's founding team?
- In November 2025, Cassidy Bio noted that its founders bring expertise from CRISPR, AI, and biotech, which is crucial for improving the safety and specificity of gene editing therapies.